June 23, 2026 Press Release: Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses
June 23, 2026 Lloyds Energy Ltd Announces Strategic Evaluation of LNG and Regasification Opportunities Across Emerging Energy Markets
